Professor Amin Kassis, a distinguished Radiology Professor at Harvard Medical School and Director of Radiobiology and Experimental Radionuclide Therapy at Brigham and Women’s Hospital, has made significant contributions to nuclear medicine. Since joining Harvard in 1978, Kassis has led innovative projects focused on understanding radioactivity’s effects on cells, developing radiopharmaceuticals for imaging and treating tumors, and creating non-invasive blood assays to detect hidden cancers.

He has held notable positions, including the directorship of the Laboratory for Radionuclide Gynaecologic Oncology at Dana-Farber Cancer Institute, and chaired the Task Force on Dosimetry of Radiolabelled Antibodies within the Society of Nuclear Medicine. His research has received over $20 million in grants from the NIH, Department of Defense, and Department of Energy. Recognized with the Loevinger-Berman and President’s Awards, Kassis is celebrated for his advancements in radiology and nuclear medicine.

A prolific researcher, he has published over 180 peer-reviewed articles and holds 63 patents. His biomedical inventions include the EMCIT Technology and SNEP Assay, licensed by Sabik Medical and OncoCell MDx. Born in Syria, Kassis earned his BS and MS from the American University of Beirut and his PhD in Immunology/Parasitology from McGill University. His pioneering work continues to shape the fields of oncology and nuclear medicine.